Brain Metabolic Mapping with MRS: A Potent Noninvasive Tool for Clinical Diagnosis of Brain Disorders

References

1. 1.↵
   1. Murphy-Boesch J,
   2. Stoyanova R,
   3. Srinivasan R,
   4. et al

   . Proton-decoupled 31P chemical shift imaging of the human brain in normal volunteers. NMR Biomed 1993;6:173–80

   CrossRefPubMedGoogle Scholar
2. 2.↵
   1. Mandal PK,
   2. Tripathi M,
   3. Sugunan S

   . Brain oxidative stress: detection and mapping of anti-oxidant marker glutathione in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy. Biochem Biophys Res Commun 2012;417:43–48

   CrossRefPubMedGoogle Scholar
3. 3.↵
   1. Mirowitz SA,
   2. Sartor K,
   3. Prensky AJ,
   4. et al

   . Neurodegenerative diseases of childhood: MR and CT evaluation. J Comput Assist Tomogr 1991;15:210–22

   CrossRefPubMedWeb of ScienceGoogle Scholar
4. 4.↵
   1. Vion-Dury J,
   2. Meyerhoff DJ,
   3. Cozzone PJ,
   4. et al

   . What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy? J Neurol 1994;241:354–71

   CrossRefPubMedWeb of ScienceGoogle Scholar
5. 5.↵
   1. Rossi A,
   2. Biancheri R

   . Magnetic resonance spectroscopy in metabolic disorders. Neuroimaging Clin N Am 2013;23:425–48

   CrossRefPubMedGoogle Scholar
6. 6.↵
   1. Gao F,
   2. Barker PB

   . Various MRS application tools for Alzheimer disease and mild cognitive impairment. AJNR Am J Neuroradiol 2014 Apr 17. [Epub ahead of print]

   Google Scholar
7. 7.↵
   Alzheimers Disease International. World Alzheimer report 2009. http://www.alz.co.uk/research/world-report. Accessed June 4, 2014

   Google Scholar
8. 8.↵
   1. Kantarci K

   . Molecular imaging of Alzheimer disease pathology. AJNR Am J Neuroradiol 2014 Feb 6. [Epub ahead of print]

   Google Scholar
9. 9.↵
   1. Carter SF,
   2. Embleton KV,
   3. Anton-Rodriguez JM,
   4. et al

   . Regional neuronal network failure and cognition in late-onset sporadic Alzheimer disease. AJNR Am J Neuroradiol 2014 Feb 27. [Epub ahead of print]

   Google Scholar
10. 10.↵
    1. Maudsley AA,
    2. Gupta RK,
    3. Stoyanova R,
    4. et al

    . Mapping of glycine distributions in gliomas. AJNR Am J Neuroradiol 2014 Jan 30. [Epub ahead of print]

    Google Scholar
11. 11.↵
    1. Dani KA,
    2. Warach S

    . Metabolic imaging of ischemic stroke: the present and future. AJNR Am J Neuroradiol 2014 Apr 10. [Epub ahead of print]

    Google Scholar
12. 12.↵
    1. Lee TS,
    2. Quek SY,
    3. Krishnan KR

    . Molecular imaging for depressive disorders. AJNR Am J Neuroradiol 2014 May 15. [Epub ahead of print]

    Google Scholar
13. 13.↵
    1. Altabella L,
    2. Zoratto F,
    3. Adriani W,
    4. et al

    . MR imaging-detectable metabolic alterations in attention deficit/hyperactivity disorder: from preclinical to clinical studies. AJNR Am J Neuroradiol 2014 Jan 30. [Epub ahead of print]

    Google Scholar
14. 14.↵
    1. Kondo DG,
    2. Hellem TL,
    3. Shi XF,
    4. et al

    . A review of MR spectroscopy studies of pediatric bipolar disorder. AJNR Am J Neuroradiol 2014 Feb 20. [Epub ahead of print]

    Google Scholar
15. 15.↵
    1. Sarma MK,
    2. Nagarajan R,
    3. Macey PM,
    4. et al

    . Accelerated echo-planar J-resolved spectroscopic imaging in the human brain using compressed sensing: a pilot validation in obstructive sleep apnea. AJNR Am J Neuroradiol 2014 Feb 6. [Epub ahead of print]

    Google Scholar